"Your competitors filed digitally last quarter. You're still printing."
Chief Information Officer
Fortune 500 Pharmaceutical Group
GMP Facility · ISO 13485
Legacy. Transformed.
The moment the old system finally failed — and what happened next.
Three engagements. Three distinct failure points. One consistent finding: the infrastructure was the problem, not the people.
"The audit started at 9 AM. By noon, three inspectors were still waiting for us to locate a paper batch record from 2019. We found it at 4:47 PM."
Twelve weeks after migration, our QA team ran the same audit type in under two hours. The records were there before the inspector sat down.
VP Quality & Compliance
Mid-Cap Specialty Pharma · $2.4B Revenue
Reduction in audit preparation time
From 4.2 days average to 0.9 days across all site audits within 6 months of CSV/CSA migration
Compressed from first molecule data to IND filing
Previous average: 26 months. Post-digitization average across 3 consecutive programs: 12 months
"We printed 847 pages for a Type II variation. The submission coordinator had a repetitive strain injury. That was the moment I knew we had a structural problem, not a staffing problem."
The first fully digital submission went out in eleven days. The previous comparable submission took nine months of assembly.
Head of Regulatory Affairs, Europe
CDMO · 5 concurrent client programs
"We had five validation systems, three electronic batch record platforms, and two legacy LIMS installations. Every integration was a custom build maintained by one person who was about to retire."
Eighteen months later, every site runs on a single validated ecosystem. The person who was retiring stayed — because his job became interesting again.
Chief Information Officer
Global Pharma Manufacturer · 14 sites across 6 countries
Increase in cross-site data accessibility
Unified data layer across all 14 manufacturing sites — enabling real-time batch deviation analysis that previously required 6-week manual consolidation
Schedule an
Executive Briefing
A focused 60-minute conversation for senior digital and regulatory leaders. No slides. No sales pitch. A direct assessment of where your systems are costing you time.
PharmaTransform Research · 2024
2024 Pharma Digital Maturity Benchmark
Where mid-cap pharma firms actually stand on digital validation, submission readiness, and data infrastructure — benchmarked against 47 organizations across 8 therapeutic areas.
Not ready for a conversation? Download the benchmark report. See where your organization sits — and what the top quartile is doing differently.